This session will discuss the randomized clinical trial data on FDA approved forms of pre-exposure prophylaxis (PrEP) and review CDC guidelines on PrEP for the prevention of HIV infection.

Learning Objectives:

• Describe current demographics and HIV transmission in NJ
• Define Pre-exposure prophylaxis (PrEP) and list FDA approved forms of PrEP.
• Examine/summarize randomized clinical trial data.
• Discuss CDC guidelines on PrEP for the prevention of HIV infection.